SEARCH RESULTS FOR: "Tag: STIM"
loading image
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2018(1)
CATEGORIES
Analyst Update(1)

7/24/2018 2:29 PM
Canaccord Genuity initiated coverage on Neuronetics Inc (NASDAQ:STIM) with a "buy" rating, and a $33 price target -- a 27% premium to last night's close, and uncharted territory for the Wall Street n...
PEOPLE ALSO SEARCH FOR
 
Special Offers from Schaeffer's Trading Partners